BDPT (BioAdaptives) Shiller PE Ratio: (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BioAdaptives Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioAdaptives  (OTCPK:BDPT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BioAdaptives Shiller PE Ratio Related Terms


BioAdaptives Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for BioAdaptives's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioAdaptives Shiller PE Ratio Chart

BioAdaptives Annual Data
Trend Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioAdaptives Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BDPT vs KHC, GIS, MKC: Shiller PE Ratio Comparison

For the Packaged Foods subindustry, BioAdaptives's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioAdaptives Shiller PE Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioAdaptives's Shiller PE Ratio falls into.



BioAdaptives Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioAdaptives's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, BioAdaptives's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/333.9520*333.9520
=0.000

Current CPI (Jun. 2026) = 333.9520.

BioAdaptives Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.349 236.119 -0.494
201506 -1.500 238.638 -2.099
201509 -0.473 237.945 -0.664
201512 -1.500 236.525 -2.118
201603 -1.500 238.132 -2.104
201606 -0.351 241.018 -0.486
201609 -0.278 241.428 -0.385
201806 -3.000 251.989 -3.976
201809 -6.000 252.439 -7.937
201812 -3.000 251.233 -3.988
201903 1.500 254.202 1.971
201906 -1.500 256.143 -1.956
201909 -0.440 256.759 -0.572
201912 0.000 256.974 0.000
202003 -1.500 258.115 -1.941
202006 -3.000 257.797 -3.886
202009 -0.097 260.280 -0.124
202012 -1.500 260.474 -1.923
202103 -3.000 264.877 -3.782
202106 -1.500 271.696 -1.844
202109 -0.153 274.310 -0.186
202112 0.000 278.802 0.000
202203 -1.500 287.504 -1.742
202206 -0.497 296.311 -0.560
202209 -0.464 296.808 -0.522
202212 -0.017 296.797 -0.019
202303 -0.161 301.836 -0.178
202306 -0.049 305.109 -0.054
202309 -0.003 307.789 -0.003
202312 -0.045 306.746 -0.049
202403 -0.040 312.332 -0.043
202406 -0.030 314.175 -0.032
202409 0.000 315.301 0.000
202412 -0.040 315.605 -0.042
202503 -0.020 319.799 -0.021
202506 -0.020 322.561 -0.021
202509 -0.040 324.800 -0.041
202512 -0.070 324.054 -0.072
202603 -0.010 330.213 -0.010
202606 0.000 333.952 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioAdaptives Business Description

Address 2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.